Characterization of Bacteroides fragilis from the vagina of a giant panda (Ailuropoda melanoleuca) with vaginitis

BMC Vet Res. 2024 Nov 27;20(1):528. doi: 10.1186/s12917-024-04401-4.

Abstract

Background: Bacteroides fragilis is a prevalent anaerobic bacterium typically resides in the human vagina. It is known to potentially induce infections under specific conditions. Interestingly, there have been no previous reports of B. fragilis being isolated from the vagina of giant pandas.

Case presentation: A novel strain of anaerobic bacteria was isolated from the vaginal tract of a giant panda exhibiting symptoms of vaginitis. This strain, designated as GPBF01, was identified as Bacteroides fragilis, a species commonly found in the vaginal microbiome of humans and other animals. After purifying of the single colony, a series of evaluations were conducted including morphological examination, physiological and biochemical identification, antibiotic resistance analysis, resistance genes detection, 16S rRNA sequence, and phylogenetic tree sequence analysis to investigate its biological characteristics. The findings indicated the presence of a predominant anaerobic bacterium, which was identified as B. fragilis and temporarily named GPBF01 with unique biological traits not previously.

Conclusions: This study is the first to report B. fragilis in the vaginal tract of giant pandas. The analysis of antibiotic resistance patterns among anaerobic bacteria, as conducted in this research, is critical for informing the selection of appropriate antimicrobial agents in the clinical treatment of vaginitis in this species. The findings of this report substantially enhance the scientific basis needed to understand the etiology and refine therapeutic approaches for vaginitis in giant pandas.

Keywords: Bacteroides fragilis; 16S Rrna; Antibiotic resistance; Giant panda; Physiological and biochemical reactions.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteroides Infections / drug therapy
  • Bacteroides Infections / microbiology
  • Bacteroides Infections / veterinary
  • Bacteroides fragilis* / genetics
  • Bacteroides fragilis* / isolation & purification
  • Drug Resistance, Bacterial
  • Female
  • Phylogeny*
  • RNA, Ribosomal, 16S* / genetics
  • Ursidae* / microbiology
  • Vagina* / microbiology
  • Vaginitis / drug therapy
  • Vaginitis / microbiology
  • Vaginitis / veterinary

Substances

  • RNA, Ribosomal, 16S
  • Anti-Bacterial Agents